Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 377 citing articles:

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Laure Gossec, Josef S Smolen, Sofía Ramiro, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 3, pp. 499-510
Open Access | Times Cited: 885
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 700.1-712
Open Access | Times Cited: 834
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials
Ana‐Maria Orbai, Maarten de Wit, Philip J. Mease, et al.
Annals of the Rheumatic Diseases (2016) Vol. 76, Iss. 4, pp. 673-680
Open Access | Times Cited: 229
Psoriatic arthritis
Oliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 194
Emerging Guidelines for Patient Engagement in Research
John Kirwan, Maarten de Wit, Lori Frank, et al.
Value in Health (2016) Vol. 20, Iss. 3, pp. 481-486
Open Access | Times Cited: 179
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
Laura C. Coates, Robert Landewé, Iain B. McInnes, et al.
RMD Open (2024) Vol. 10, Iss. 1, pp. e003855-e003855
Open Access | Times Cited: 18
Axial spondyloarthritis
Joachim Sieper, J. Braun, Maxime Dougados, et al.
Nature Reviews Disease Primers (2015) Vol. 1, Iss. 1
Closed Access | Times Cited: 159
Quality of life in psoriatic arthritis
Tania Gudu, Laure Gossec
Expert Review of Clinical Immunology (2018) Vol. 14, Iss. 5, pp. 405-417
Open Access | Times Cited: 155
The psychosocial burden of psoriatic arthritis
M. Elaine Husni, Joseph F. Merola, Sara Davin
Seminars in Arthritis and Rheumatism (2017) Vol. 47, Iss. 3, pp. 351-360
Open Access | Times Cited: 153
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
Christopher T. Ritchlin, Arthur Kavanaugh, Joseph F. Merola, et al.
The Lancet (2020) Vol. 395, Iss. 10222, pp. 427-440
Closed Access | Times Cited: 133
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016
Ana‐Maria Orbai, Maarten de Wit, Philip J. Mease, et al.
The Journal of Rheumatology (2017) Vol. 44, Iss. 10, pp. 1522-1528
Open Access | Times Cited: 122
Itch: an under‐recognized problem in psoriasis
Boni E. Elewski, Andrew Alexis, Mark Lebwohl, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 33, Iss. 8, pp. 1465-1476
Closed Access | Times Cited: 78
Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study
Philip J. Mease, Saima Chohan, Ferran José García Fructuoso, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 9, pp. 1147-1157
Open Access | Times Cited: 67
EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update
Maarten de Wit, K. Aouad, Muriel Elhaï, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225566
Closed Access | Times Cited: 11
The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission
L. van Tuyl, M. Sadlonova, Sarah Hewlett, et al.
Annals of the Rheumatic Diseases (2016) Vol. 76, Iss. 5, pp. 855-861
Open Access | Times Cited: 85
Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology
Maarten de Wit, Tore K Kvien, Laure Gossec
RMD Open (2015) Vol. 1, Iss. 1, pp. e000129-e000129
Open Access | Times Cited: 77
Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials
Ana‐Maria Orbai, Clifton O. Bingham
Current Rheumatology Reports (2015) Vol. 17, Iss. 4
Open Access | Times Cited: 75
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries
Clémence Gorlier, Ana‐Maria Orbai, Déborah Puyraimond‐Zemmour, et al.
Annals of the Rheumatic Diseases (2018) Vol. 78, Iss. 2, pp. 201-208
Open Access | Times Cited: 74
Promoting patient‐centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience
Neil Betteridge, Wolf‐­Henning Boehncke, Christine Bundy, et al.
Journal of the European Academy of Dermatology and Venereology (2015) Vol. 30, Iss. 4, pp. 576-585
Open Access | Times Cited: 72
The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical Setting
Marco Di Carlo, Andrea Becciolini, Valentina Lato, et al.
The Journal of Rheumatology (2016) Vol. 44, Iss. 3, pp. 279-285
Closed Access | Times Cited: 72
Determinants of Patient‐Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study
Carole Desthieux, Benjamin Granger, Andra Bălănescu, et al.
Arthritis Care & Research (2016) Vol. 69, Iss. 10, pp. 1606-1611
Open Access | Times Cited: 71
Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study
Rubén Queiró, Juan D. Cañete, Carlos Montilla, et al.
Arthritis Research & Therapy (2017) Vol. 19, Iss. 1
Open Access | Times Cited: 71
Outcome Measures in Psoriatic Arthritis
Laura C. Coates
Rheumatic Disease Clinics of North America (2015) Vol. 41, Iss. 4, pp. 699-710
Closed Access | Times Cited: 67
Patient-Reported Outcomes in Psoriatic Arthritis
Ana‐Maria Orbai, Alexis Ogdie
Rheumatic Disease Clinics of North America (2016) Vol. 42, Iss. 2, pp. 265-283
Open Access | Times Cited: 61
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch, et al.
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top